These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1478050

  • 1. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN, Erwin ME.
    Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility testing interpretive criteria and drug stability for cefdinir, cefetamet, and cefpodoxime against Neisseria gonorrhoeae.
    Barrett MS, Jones RN.
    Diagn Microbiol Infect Dis; 1992; 15(8):685-91. PubMed ID: 1478049
    [Abstract] [Full Text] [Related]

  • 3. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
    Bale MJ, Jones RN.
    J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
    [Abstract] [Full Text] [Related]

  • 4. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L, Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [Abstract] [Full Text] [Related]

  • 5. Cefmetazole and trospectomycin in vitro susceptibility testing interpretive criteria and quality control guidelines for Neisseria gonorrheae.
    Jones RN, Erwin ME, Washington JA, Koontz FP, Murray PR, Gerlach EH.
    Diagn Microbiol Infect Dis; 1992 Aug; 15(7):627-32. PubMed ID: 1424520
    [Abstract] [Full Text] [Related]

  • 6. MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin.
    Bale MJ, Jones RN, Erwin ME, Koontz FP, Gerlach EH, Murray PR, Washington JA.
    J Clin Microbiol; 1992 Jan; 30(1):225-6. PubMed ID: 1310329
    [Abstract] [Full Text] [Related]

  • 7. Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.
    Bale MJ, Jones RN, Erwin ME, Koontz FP, Gerlach EH, Murray PR, Washington JA.
    J Clin Microbiol; 1992 Mar; 30(3):744-5. PubMed ID: 1313052
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
    Bauernfeind A, Jungwirth R.
    Infection; 1991 Mar; 19(5):353-62. PubMed ID: 1800377
    [Abstract] [Full Text] [Related]

  • 12. Preliminary disk diffusion susceptibility testing criteria for cefdaloxime (RU29246, HR-916 metabolite), a new orally administered cephalosporin.
    Jones RN, Erwin ME.
    J Clin Microbiol; 1992 May; 30(5):1297-300. PubMed ID: 1583135
    [Abstract] [Full Text] [Related]

  • 13. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
    Doern GV, Daum GS, Tubert TA.
    J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738
    [Abstract] [Full Text] [Related]

  • 14. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
    Biedenbach DJ, Jones RN.
    J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [Abstract] [Full Text] [Related]

  • 16. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD, Powell M, Fah YS, Seymour A, Yuan M.
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [Abstract] [Full Text] [Related]

  • 17. Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
    Jones RN, Barry AL.
    J Clin Microbiol; 1987 Sep; 25(9):1796-9. PubMed ID: 3654953
    [Abstract] [Full Text] [Related]

  • 18. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
    Bogdanovich T, Clark C, Ednie L, Lin G, Smith K, Shapiro S, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
    [Abstract] [Full Text] [Related]

  • 19. Interpretive criteria for disk diffusion tests using 5-microgram cefdinir disks with rapidly growing clinical isolates.
    Jones RN, Erwin ME, Gooding BB.
    J Clin Microbiol; 1992 Apr; 30(4):1022-3. PubMed ID: 1572959
    [Abstract] [Full Text] [Related]

  • 20. Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae.
    Jones RN, Barrett MS, Biedenbach DJ.
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):93-9. PubMed ID: 7805362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.